Clinical Trial Update: A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 study evaluating the safety and tolerability of deferiprone in Friedreich's ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Friedreich's Ataxia | Phase 1, Phase 2 | Status: COMPLETED